𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP)

✍ Scribed by Ayman M. Noreddin; Theodore K. Marras; Kevin Sanders; Charles K.N. Chan; Daryl J. Hoban; George G. Zhanel


Book ID
119258978
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
86 KB
Volume
24
Category
Article
ISSN
0924-8579

No coin nor oath required. For personal study only.